Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian inference on protective antibody levels using case-control data.

V J Carey1, C J Baker, R Platt

  • 1Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. stvjc@gauss.med.harvard.edu

Biometrics
|March 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four ppm measurement of the antihydrogen ground-state hyperfine splitting.

Nature·2026
Same author

Be<sup>+</sup> assisted, simultaneous confinement of more than 15000 antihydrogen atoms.

Nature communications·2025
Same author

Rotational orientation control of a ground state ortho-H<sub>2</sub> dissociation on a metal surface.

Nature communications·2025
Same author

Observation of the effect of gravity on the motion of antimatter.

Nature·2023
Same author

Human Echolocators Have Better Localization Off Axis.

Psychological science·2022
Same author

Sympathetic cooling of positrons to cryogenic temperatures for antihydrogen production.

Nature communications·2021
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
See all related articles

This study introduces a Gibbs sampling method to estimate the minimum protective antibody concentration (MPAC) for infectious diseases. The method accurately determines antibody levels that confer zero or near-zero infection risk, aiding public health strategies.

Area of Science:

  • Immunology and infectious disease research
  • Statistical modeling in epidemiology
  • Quantitative risk assessment for public health

Background:

  • The minimum protective antibody concentration (MPAC) is crucial for understanding immune responses to pathogens.
  • Accurate estimation of MPAC is essential for vaccine development and public health policy.
  • Existing methods may lack accuracy or robustness, especially with limited patient data.

Purpose of the Study:

  • To develop and validate a statistical method for estimating the posterior distribution of disease risk conditional on antibody concentration.
  • To identify a reliable method for determining the antibody concentration threshold associated with negligible infection risk.
  • To present a simple Gibbs sampling procedure for robust inference on antibody-dependent disease risk.

Related Experiment Videos

Main Methods:

  • Utilized case-control data to model the conditional risk of disease given a lower bound on antibody concentration.
  • Developed a simple Gibbs sampling procedure for Bayesian inference on disease risk.
  • Assessed the accuracy and robustness of the method with small sample sizes and varying prior specifications.
  • Employed frequentist evaluation to determine coverage probabilities of credibility intervals for antibody-dependent risk.

Main Results:

  • The proposed Gibbs sampling method demonstrates favorable accuracy and robustness, even with limited patient data and potential prior misspecification.
  • Frequentist evaluations confirmed good coverage probabilities for credibility intervals of antibody-dependent risk.
  • The study successfully illustrated rules for MPAC estimation using real-world epidemiological data.

Conclusions:

  • The developed Gibbs sampling approach provides a reliable tool for estimating antibody-dependent disease risk and identifying the MPAC.
  • This method offers a robust and accurate solution for situations with small patient cohorts.
  • The findings have direct implications for public health, guiding decisions on vaccination and disease prevention strategies based on antibody levels.